{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:06:32Z","timestamp":1773288392771,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1532\/ijh97.05134","type":"journal-article","created":{"date-parts":[[2007,10,18]],"date-time":"2007-10-18T14:04:01Z","timestamp":1192716241000},"page":"164-178","source":"Crossref","is-referenced-by-count":18,"title":["Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan"],"prefix":"10.1007","volume":"83","author":[{"given":"Masahiro","family":"Imamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetaka","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisei","family":"Kawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsutoshi","family":"Nakahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Shiobara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsune","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hamajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Thomas ED. Bone marrow transplantation: a review. <i>Semin Hematol.<\/i> 1999;36(suppl 7):95-103."},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Craddock C. Haematopoietic stem-cell transplantation: recent progress and future promise. <i>Lancet Oncol.<\/i> 2000;1:227-234.","DOI":"10.1016\/S1470-2045(00)00153-4"},{"key":"E00003","unstructured":"Nieto Y, Jones RB, Shpall EL. Stem-cell transplantation for the treatment of advanced solid tumors. <i>Springer Semin Immunopathol.<\/i> 2004;26:31-56."},{"key":"E00004","unstructured":"Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. <i>Bone Marrow Transplant.<\/i> 2005;36:575-590."},{"key":"E00005","unstructured":"Barrett J, Childs R. Non-myeloablative stem cell transplants. <i>Br J Haematol.<\/i> 2000;111:6-17."},{"key":"E00006","unstructured":"Kanda Y, Chiba S, Hirai H, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). <i>Blood.<\/i> 2003;102: 1541-1547."},{"key":"E00007","unstructured":"Izutsu K, Kanda Y, Ohno H, et al. Unrelated bone marrow transplantation from non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. <i>Blood.<\/i> 2004;103:1955-1960."},{"key":"E00008","unstructured":"Kameoka I, Kami M, Takahashi S, et al. Clinical impact of graftversus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. <i>Bone Marrow Transplant.<\/i> 2004;34:711-719."},{"key":"E00009","unstructured":"Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. <i>Blood.<\/i> 1996;88:795-802."},{"key":"E00010","unstructured":"Miyakoshi S, Yuji K, Kami M, et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. <i>Clin Cancer Res.<\/i> 2004;10:3586-3592."},{"key":"E00011","unstructured":"Madrigal JA, Cohen SB, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. <i>Hum Immunol.<\/i> 1997;56:1-5."},{"key":"E00012","unstructured":"Morishima Y, Morishita Y, Tanimoto M, et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group. <i>Blood.<\/i> 1989;74:2252-2256."},{"key":"E00013","unstructured":"Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. <i>N Engl J Med.<\/i> 1998;339:1177-1185."},{"key":"E00014","unstructured":"Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. <i>Blood.<\/i> 1995;86:1606-1613."},{"key":"E00015","unstructured":"Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. <i>Blood.<\/i> 2002;99:4200-4206."},{"key":"E00016","unstructured":"Zittoun RA, Mandelli F, Willemze R, et al, for the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Research Cooperative Groups. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. <i>N Engl J Med.<\/i> 1995;332:217-223."},{"key":"E00017","unstructured":"Burnett AK, Goldstone AH, Stevens RMF, et al, for the UK Medical Research Council Adult and Children's Leukaemia Working Parties. Randomised comparison of addition of autologous bonemarrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. <i>Lancet.<\/i> 1998;351:700-708."},{"key":"E00018","unstructured":"Cassileth PA, Harrington DP, Appelbaum FR, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. <i>N Engl J Med.<\/i> 1998;339:1649-1666."},{"key":"E00019","unstructured":"Gondo H, Harada M, Miyamoto T, et al. Autologous peripheral stem cell transplantation for acute myelogenous leukemia. <i>Bone Marrow Transplant.<\/i> 1997;20:821-826."},{"key":"E00020","unstructured":"Thomas X, Boiron J-M, Huguet F, et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. <i>J Clin Oncol.<\/i> 2004;22:4075-4086."},{"key":"E00021","unstructured":"Kiehl MG, Kraut L, Schwerdtfeger R, et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. <i>J Clin Oncol.<\/i> 2004;22:2816-2825."},{"key":"E00022","unstructured":"Nordlander A, Mattsson J, Ringden O, et al. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. <i>Biol Blood Marrow Transplant.<\/i> 2004;10:195-203."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Gorin NC. Autologous stem cell transplantation in acute lymphocytic leukemia. <i>Stem Cells.<\/i> 2002;20:3-10.","DOI":"10.1634\/stemcells.20-1-3"},{"key":"E00024","unstructured":"Druker BJ, O'Brien SG, Cortes J, Radich J. Chronic myelogenous leukemia. <i>Hematology (Am Soc Hematol Educ Program).<\/i> 2002;1:111-135."},{"key":"E00025","unstructured":"Horowitz MM, Rowlings PA, Passweg JR. Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. <i>Bone Marrow Transplant.<\/i> 1996;17(suppl 3):S5-S6."},{"key":"E00026","unstructured":"Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors of patients with chronic myeloid leukemia. <i>N Engl J Med.<\/i> 1998;338:962-968."},{"key":"E00027","unstructured":"Davies SM, DeFor TE, McGlave PB, et al. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. <i>Am J Med.<\/i> 2001;110:339-346."},{"key":"E00028","unstructured":"Appelbaum FR, Anderson A. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. <i>Leukemia.<\/i> 1998;12(suppl 1):S25-S29."},{"key":"E00029","unstructured":"Runde V, de Witte T, Arnold R, et al, on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. <i>Bone Marrow Transplant.<\/i> 1998;21:255-261."},{"key":"E00030","unstructured":"Sierra J, Perez WS, Rozman C, et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. <i>Blood.<\/i> 2002;200:1997-2004."},{"key":"E00031","unstructured":"Castro-Malaspina H, Harris RE, Gajewski J, et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. <i>Blood.<\/i> 2002;99:1943-1951."},{"key":"E00032","unstructured":"Bacigalupo A, Hows J, Gordon-Smith EC, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. <i>Bone Marrow Transplant.<\/i> 1998;3:531-535."},{"key":"E00033","unstructured":"Hows JM, Szydlo R, Anasetti C, et al. Unrelated donor marrow transplants for severe acquired aplastic anemia. <i>Bone Marrow Transplant.<\/i> 1992;10:102-106."},{"key":"E00034","unstructured":"Keran NA, Bartsh G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. <i>N Engl J Med.<\/i> 1993;328:593-602."},{"key":"E00035","unstructured":"Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. <i>Blood.<\/i> 2002;100:799-803."},{"key":"E00036","unstructured":"Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. <i>Blood.<\/i> 1998;92:3515-3520."},{"key":"E00037","unstructured":"Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. <i>Blood.<\/i> 2004; 103:2490-2497."},{"key":"E00038","unstructured":"Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. <i>N Engl J Med.<\/i> 1995;333:1540-1545."},{"key":"E00039","doi-asserted-by":"crossref","unstructured":"Vose J. High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma. <i>Ann Oncol.<\/i> 1998;9(suppl 1):S1-S3.","DOI":"10.1093\/annonc\/9.suppl_1.S1"},{"key":"E00040","unstructured":"Shipp MA, A beloff MD, Antman KH, et al. International Consensus Conference on High-Dose Therapy in Aggressive Non-Hodgkin's Lymphomas: report of the jury. <i>J Clin Oncol.<\/i> 1999;17:423-429."},{"key":"E00041","unstructured":"Kusumi E, Kami M, Kanda Y, et al. Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan. <i>Bone Marrow Transplant.<\/i> 2005;36:205-213."},{"key":"E00042","unstructured":"Hosing C, Saliba RM, McLaughlin P, et al. Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma. <i>Ann Oncol.<\/i> 2003;14:737-744."},{"key":"E00043","unstructured":"Akpek G, Ambinder RF, Piantadosi S, et al. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. <i>J Clin Oncol.<\/i> 2001;23:4314-4321."},{"key":"E00044","unstructured":"Gajewski JL, Phillips GL, Sobocinski KA, et al. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. <i>J Clin Oncol.<\/i> 1996;14:572-578."},{"key":"E00045","unstructured":"Milpied N, Fielding AK, Pearce RM, Ernst P, Goldstone AH. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease: European Group for Blood and Bone Marrow Transplantation. <i>J Clin Oncol.<\/i> 1996;14:1291-1296."},{"key":"E00046","unstructured":"Cunningham DH, Paz-Ares L, Milan S, et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. <i>J Clin Oncol.<\/i> 1994;12:759-763."},{"key":"E00047","unstructured":"Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma: Intergroupe Francais du Myelome. <i>N Engl J Med.<\/i> 1996;335:91-97."},{"key":"E00048","unstructured":"Child J, Morgan G, Davies F, et al, for the Medical Research Council Adult Leukaemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. <i>N Engl J Med.<\/i> 2003;348:1875-1883."},{"key":"E00049","unstructured":"Bensinger W, Maloney D, Storb R. Allogeneic hematopoietic cell transplantation for multiple myeloma. <i>Semin Hematol.<\/i> 2001;38:243-249."},{"key":"E00050","unstructured":"Barlogie B, Jagannath S, Vesole D, et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. <i>Blood.<\/i> 1997;89:789-793."},{"key":"E00051","unstructured":"Bardos A, Barlogie B, Siegel E, et al. Improved outcome of nonmyeloablative allogeneic transplantation in multiple myeloma. <i>J Clin Oncol.<\/i> 2002;20:1295-1303."},{"key":"E00052","unstructured":"Maloney DG, Molina AJ, Sahebi F, et al. Allografting with nonmyeloablative conditioning following cytoreductive autografting for the treatment of patients with multiple myeloma. <i>Blood.<\/i> 2003;102:3447-3454."},{"key":"E00053","unstructured":"Barlogie B, Shaughnessy J, Tricot G, et al. Treatment of multiple myeloma. <i>Blood.<\/i> 2004;103:20-32."},{"key":"E00054","unstructured":"Childs R, Chemoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheralblood stem-cell transplantation. <i>N Engl J Med.<\/i> 2000;343:750-758."},{"key":"E00055","unstructured":"Ueno NT, Cheng YC, Rondon G, et al. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. <i>Blood.<\/i> 2003;102:3829-3836."}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.05134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T21:15:19Z","timestamp":1556918119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.05134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["5137352728410751"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.05134","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}